Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation — Positive Advanced Non–Small Cell Lung Cancer (CheckMate 370)

David R. Spigel, Craig H. Reynolds, David Waterhouse, +9

Journal of Thoracic Oncology

Phase 1/2MedicineImmunologyPathologyCheckmate 370 +7

Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial

Jeremy Sokolove, Michael Schiff, Roy Fleischmann, +7

Annals of the Rheumatic Diseases

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

Huilin Zhang, Jinrong Qiu, Chunping Ye, +10

Scientific Reports

Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer

Hong Lin, Jianfei Huang, Jinrong Qiu, +7

Experimental and Molecular Pathology

Cyclin D1 CorrelateUpregulated Tacstd2OncologyBreast OncologyMedicine +8

Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis

Yu He, Xiangde Liu, Zhiyu Chen, +5

Clinical Cancer Research

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma

Jianfei Huang, Xialing Zhang, Qi Tang, +4

Journal of Clinical Pathology

Activation of Microglia by Histamine and Substance P

Jin Zhu, Chen Qu, Xiang Lü, +1

Cellular Physiology and Biochemistry

A novel human Fab antibody for Trop2 inhibits breast cancer growth <i>in vitro</i> and <i>in vivo</i>

Hong Lin, Huiling Zhang, Jun Wang, +11

International Journal of Cancer

Breast OncologyMedicineImmunologyTumor ImmunityCancer Cell Biology +11

Trop2 is overexpressed in gastric cancer and predicts poor prognosis

Wei Zhao, Huijun Zhu, Shu Zhang, +9

Oncotarget

The killing effect of novel bi-specific Trop2/PD-L1 CAR-T cell targeted gastric cancer.

Wei Zhao, Lizhou Jia, Mingjiong Zhang, +5

PubMed